ABL:ETR
Abbott Laboratories
€92.62
arrow_downward
-0.26%(-0.24) 1D
Oct 19, 5:09:55 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABL...
Open
€92.94
High
€93.94
Low
€92.42
Mkt. cap
179.64B
Avg. vol.
659.00
Volume
90.00
52-wk high
€113.52
52-wk low
€70.10
No. of employees
115K
Open
€92.94
High
€93.94
Low
€92.42
Mkt. cap
179.64B
Avg. vol.
659.00
Volume
90.00
52-wk high
€113.52
52-wk low
€70.10
No. of employees
115K
News stories
From web sources and news partners
Investing.com
·
34 minutes ago
UBS reiterates Buy on Abbott Labs stock, cites biosimilars pipeline
ad-hoc-news.de
·
40 minutes ago
Abbott Laboratories stock: TD Cowen keeps USD 135.00 target for Abbott Laboratories stock
TradingView
·
2 hours ago
Abbott Laboratories expected to post earnings of $1.42 a share - Earnings Preview
Benzinga
·
4 hours ago
Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q3 Earnings
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.
The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115K
Founded1888
HeadquartersChicago, Illinois, United States
SectorMedical device
Websiteabbott.com